Eptus. In generics, we are developing high quality affordable products for markets such as US and Europe. Glenmark Life Sciences—IPO How to Check Allotment ... Over the years, they have established strong relationships with leading global generic pharmaceutical companies that have helped us expand their product offerings and geographic reach. Low Risk Stock is 1.49x as volatile as Nifty. Glenmark has sought regulatory clearance on the product and will undertake advanced clinical trials in India. 2. 4) IPO Lot Size and Reservations Glenmark Life Sciences Limited PE Ratio is 16.79262400 now. With 18+ years' experience in API development and manufacturing, we are well positioned to meet our customers' API & intermediates outsourcing needs. Glenmark Life Sciences IPO Opens Tomorrow: Issue Size ... Glenmark Life Sciences Limited ("GLS") is a Rs. equity shares of the face value of ₹2 aggregating up to ₹1,513.60 Crores. Glenmark Life Sciences listing: No bumper gains; shares ... The offer will close on July 29.BThe company has set a price band at Rs695 - Rs720 per equity share. The company was founded on June 23, 2011 and is headquartered in Mumbai . Read more. The public issue, which began today (July 27) will close . On the NSE, the shares listed at ₹ 750. Glenmark Life Sciences Ltd . 215,609,904. GLS Stock Price and Chart — NSE:GLS — TradingView — IndiaGlenmark Life Sciences IPO: Shares list at 4% premium on ... Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Glenmark Life Sciences shares make tepid debut, gain 4% ... The company is completely owned by Glenmark Pharma that develops and manufactures active pharmaceutical ingredients. The price band of Glenmark Life Sciences IPO has been fixed at Rs 695-720 per share and a retail investor can bid for a total of 13 lots. It has more than 120 products in its portfolio and exports APIs to multiple countries in . . To receive medical or safety information or to report a product complaint or side effect (also called an adverse event), please contact the Glenmark customer service center at: globalcustomerservice@glenmarkpharma.com or at. Glenmark Life Sciences, one of the leading manufacturers of select high value, non-commoditised, low-cost active pharmaceutical ingredients in chronic therapeutic areas, is all set to launch its initial public offering (IPO) on Tuesday.The company aims to raise Rs 1,514 crore from primary market investors. Join Us | GlenmarkGlenmark Life Sciences Limited GLS.NS Price Today on NSE ... Glenmark Life Sciences is the API (active pharmaceutical ingredients) arm of Glenmark Pharmaceuticals. Glenmark Life Sciences Limited Share Price Today, Stock ... The company is planning on generating 1,497.85 crore at the lower end of the price band which is Rs 695. Glenmark Life Sciences IPO - *Market's Current Estimates of oversubscription*: NII = 35KCrs. Glenmark Life Sciences Glenmark Life Sciences IPO Subscribed 5.90 Times On Day 2. The company went public in India in 1999, and used some of the proceeds . It is classified as Non-govt company and is registered at Registrar of Companies, Pune. At 11:50 am, Glenmark . Glenmark Life Sciences Ltd is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients 2022-01-03 14:00:39 Toggle navigation 3 locations where our R&D centres are present. Glenmark Life Sciences Ltd.'s Rs 1,514-crore initial public offering continued to witness strong retail investor interest on the second day of subscription.The IPO was subscribed more than two times on the first day, led by retail demand. Glenmark Life Science Main Products are a Manufacturer of Medicine and Other Pharma Products. Glenmark Life Sciences Limited Share Price Today, Live NSE Stock Price: Get the latest Glenmark Life Sciences Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results and more details at NSE India. We have a strong pipeline of novel molecules in various stages of pre-clinical and clinical development that is focussed on meeting the unmet medical needs of the world. 1 minute 5 minutes 15 minutes 30 minutes 1 hour 2 hours 4 hours 1 day 1 week 1 month Glenmark Life Sciences is a developer and manufacturer of high-value, non-commoditised APIs (active pharmaceutical ingredients). 2,000 Cr developer and manufacturer of select active pharmaceutical ingredients ("APIs") in chronic therapeutic areas. Active Pharmaceutical Ingredients Glenmark Life Sciences (GLS), an independent unit of Glenmark Pharmaceuticals, manufactures a range of high-quality Active Pharmaceutical Ingredients (APIs) for customers worldwide. Both measures can lead to ₹1000- ₹1200 crore debt reduction and can trigger a re . Glenmark Life Sciences IPO: The company has debt-to-equity of 1.3x with a debt of Rs 916 crore which includes Rs 800 crore payable to Glenmark Pharmaceuticals, post-IPO debt will be negligible. Glenmark Life Sciences IPO: The company has debt-to-equity of 1.3x with a debt of Rs 916 crore which includes Rs 800 crore payable to Glenmark Pharmaceuticals, post-IPO debt will be negligible. Glenmark Consolidated March 2021 Net Sales at Rs 2,859.90 crore, up 3.34% Y-o-Y 06.10.2021 Glenmark Pharmaceuticals Q2 PAT seen up 18.4% YoY to Rs 269.5 cr: Prabhudas Lilladher Glenmark Life Sciences Limited, a manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, is planning to launch its initial . Its authorized share capital is Rs. industry with the latest methods and the advantages of scale to accelerate the delivery of pharmaceutical products to patients worldwide. Glenmark Life Sciences IPO is a main-board IPO of [.] Read more. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. About Glenmark Life Sciences Limited. It is a subsidiary of Glenmark Pharmaceuticals. It also contains the Live Stock Price and Volume, 52 Week High Low, Bid and Offer Price and Volume, Intraday and Historical Price Chart. Our key chemistry capabilities include polymorphism screening and optimization; pharmaceutical salt screening and optimization; cryogenic reactions; high pressure reactions; high temperature reactions; asymmetric hydrogenation; enzymatic transformations; and particle size distribution studies. They are in the business of making high-quality drugs by unlocking the possibilities of science. Buzz Health & Life Sciences (ASO Group) . Results are available at a quick glance. The store deals in varied categories of OTC, Ayurvedic, Herbal, Organic and Natural Products . A + A -. Moderate Risk Stock is 2.10x as volatile as Nifty. 3) It has strong relationship with leading global generic . The IPO saw very robust participation from its investors in the retail segment, the Qualified Institutional Buyers (QIBs) and Non-Institutional Investor (NII) category. Glenmark Life Sciences Limited opened its initial public offering (IPO) of Rs 1,514 crore on July 27 and closed its subscription on July 29, 2021. Glenmark Life Science Main Medicine Is pain, diabetes, gastrointestinal, anti-infectives, and other Medicine Manufacturer. The Balance Sheet Page of Glenmark Life Sciences Ltd. presents the key ratios, its comparison with the sector peers and 5 years of Balance Sheet. Glenmark Life Sciences has a portfolio of over 120 molecules and supplies its products to customers in India, Europe, North America, Latin America, Japan, among others. 2) It exports products in Europe, Latin America, North America, Japan, and the rest of the world. Glenmark Life Sciences Limited is a Public incorporated on 23 June 2011. Glenmark Life Sciences (GLS) IPO will open on July 27. By the end of the subscription day on July 29 at around 17:00 IST, the IPO was . Smallcap With a market cap of ₹7,663 cr, stock is ranked 400. Stock Market News: Latest Stock news and updates on The Economic Times. = ~154.16X RII = 25L Forms = 6.80X Applic. Glenmark Life Sciences: 6 Things You Should Know • Glenmark Life Sciences is the active pharma ingredients (API) arm of Glenmark Pharma. Bon D Light Drops. Glenmark Life Sciences had kept its GMP between Rs 695 and Rs 720 per share. 622.30 8.75 ( -1.39 %) Price Chart. The company develops, manufactures, and supplies high-quality . ***Products under patent are available for R&D use pursuant to 35 U.S.C. Glenmark Life Sciences initial public offering (IPO) was opened for subscription in the last leg of July with a price band of Rs 695-720 per share. Leveraging our . Brands. -0.00 chg. 0.00%. Glenmark Life Sciences Ltd Stock/Share prices today, Glenmark Life Sciences Ltd Live BSE/NSE. It has been able to build and strengthen its relationships with them on account of its strong brand equity, high quality products, R&D skills, OTHERS. Benchmarks . Glenmark Life Sciences, subsidiary of Glenmark Pharmaceuticals is all set to raise ₹1,060 crore through its IPO. 1.1 k. Health Care Pharmaceuticals. Glenmark Life Sciences' Rs 1,514-crore IPO, which opened for subscription on Tuesday, got 5.37 times applications so far on the second day of bidding, amid the ongoing selloff in pharma stocks. Glenmark's Q2 FY 2021-22 Results Glenmark's MDA Q2 FY 2021 - 22 Glenmark Pharma reports revenue growth of 6.6% and PAT growth of 10.1% YoY for Q2 FY 2021-22 Glenmark's Q1 FY 2021-22 Results Glenmark's MDA Q1 FY 2021 - 22 Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY for Q1 FY 2021-22 Know More Glenmark expects to generate ₹400 crore free cash flows in FY22 and plans an IPO for Glenmark Life Sciences. Glenmark Life's IPO comprised a fresh issue of Rs 1,060 crore and an offer for sale worth Rs 453.6 crore. The IPO received bids of over 66.33 crore shares against the total issue size of over 1.50 crore shares, according to the data available with the National Stock Exchange (NSE) showed. wise (Avg allotment of ~2.94 shares per lot) The company initially sold its products in India, Russia, and Africa. It expects to launch it in the last three months of 2021, adding to its existing basket. Glenmark Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer; he named the company after his two sons. The company and its shareholders seek to raise Rs 1,514 crore from primary market investors. Glenmark Life science is a leading developer and manufacturer os select high value , non - commoditized active pharmaceutical ingredients in chronic therapeutic areas, including cardiovascular disease, central nervous system disease , pain management and diabetes . Glenmark is a leader in the discovery of novel molecules both new chemical and new biological entities. 460,000,000 and its paid up capital is Rs. Glenmark Life Sciences Ltd. (GLSL) is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients ('APIs') in chronic therapeutic areas, including cardiovascular disease ('CVS'), central nervous system disease ('CNS'), pain management and diabetes (Source: Frost & Sullivan Report). 525.25 3.30 ( -0.62 %) Price Chart. Today, Glenmark Life Sciences accounts for 35-40% of the total valuation of Glenmark Pharma and Glenmark Life is estimated to be valued at a market cap of Rs.8,820 crore on the day of listing. Predominantly it manufactures cardiovascular disease ("CVS"), central nervous system disease ("CNS"), pain management, and . British Life Sciences; ACM Laboratoire Dermatologique; Admiris; Torrent; Alniche; Sebamed; Dr. Reddy's; Cipla; . Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Glenmark Life Sciences Ltd Live BSE Share Price today, Gls latest news, 543322 announcements. 271(e)(1). Glenmark Life Sciences is a whollyowned subsidiary of listed Glenmark Pharmaceuticals. The minimum order quantity is 20 Shares. A subsidiary of the already listed Glenmark Pharmaceuticals, Glenmark Life Sciences develops and manufactures high value, non-commoditized APIs with a portfolio of 120 products. On the National Stock Exchange (NSE), the stock of pharmaceuticals company opened at Rs 750 per share. DEBT EQUITY RATIO. Besides domestic sales, the company exports to countries in Europe, North America, Latin America, besides nations in other parts of the world including Japan. Glenmark Life Sciences (GLS) develops and manufactures a range of high-quality, industry-leading Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies worldwide. Read Full Story. This Company Also Work In Pharma Marketing In All Over India. High. As on March 31, 2021, Glenmark Life Sciences had a portfolio of 120 molecules globally, with top 10 products account for 66.36% of the revenue. A subsidiary of the already listed Glenmark Pharmaceuticals, Glenmark Life Sciences develops and manufactures high value, non-commoditized APIs with a portfolio of 120 products. Glenmark Life Sciences, subsidiary of Glenmark Pharmaceuticals is all set to raise ₹1,060 crore through its IPO. What we do. Post listing, the market . Glenmark Life Sciences raised Rs 1,513.60 crore through its public issue that was subscribed 44.17 times during July 27-29, 2021. Our experience and competencies help us intuitively understand customer needs and develop high-quality API solutions that offer an edge from an intellectual property and regulatory perspective. On listing the . Find Stock Market Live Updates, BSE, NSE Top Gainers, Losers and more. Glenmark ₹ 169 Skin Care. Shares of Glenmark Life Sciences made a decent listing on National Stock Exchange (NSE) and BSE at over 4% premium from its price band of ₹695-720 per share. Dermacare & Nutraceutical Products. Get details on Glenmark Life Sciences Ltd news, dividends, financial report, shareholding, company profile, annual report, quarterly results, profit and loss account, results and more. Sun Pharma, Lupin Pharmaceuticals, Torrent, Glenmark, Akili Interactive, and More. Glenmark Life Sciences Finished Products - Check the list of finished products by Glenmark Life Sciences on the Economic Times. Below are the . About Glenmark Life Sciences Limited. Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band. Its products are used to treat illnesses linked to cardiovascular, central nervous system therapy, diabetes and anti-infectives. Glenmark Life Sciences made a quiet debut on the bourses with the shares of the company getting listed at Rs 751.10, a 4 per cent premium against issue price of Rs 720 per share on the BSE. Glenmark Life Sciences Quarterly Results: Get the key information of Glenmark Life Sciences Q1, Q2, Q3 and Q4 results, previous Quarterly Results, Quarterly Earnings and comparison on Economic Times. Glenmark Life Sciences is a leading developer and manufacturer of select high-value, non-commoditized APIs in chronic therapeutic areas, including cardiovascular disease central nervous system. Razel EZ. The max supply of Glenmark Life Sciences Limited shares is 122,53M. 18002666255 (toll free for India) or 022-4018-9999 from 9:00AM . Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. Glenmark Life Sciences currently operate four multi-purpose manufacturing . Glenmark Life Sciences Limited PE Ratio is 16.79262400 now. Glenmark Life Sciences is the API (active pharmaceutical ingredients) arm of Glenmark Pharmaceuticals. Glenmark Life Sciences, a subsidiary of Glenmark Pharma, was incorporated in 2011 and is a leading developer and manufacturer of select high value, non-commoditised active pharma ingredients in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, diabetes. The initial public offering comprises a fresh issue of Rs 1,060 crore and an offer for . The max supply of Glenmark Life Sciences Limited shares is 122,53M. What is Glenmark Life Sciences Limited Price to Earnings Ratio (PE Ratio)? Glenmark Life Sciences is a leading developer and manufacturer of high value, non-commoditized active pharmaceutical ingredients (APIs) and its portfolio comprises of 120 products (10 products in . Glenmark Life Sciences has an IPO price band of Rs 695 to Rs 720 per equity share. Glenmark Pharmaceuticals Ltd. GLENMARK. Glenmark Life Sciences Ltd. GLS. What was Glenmark Life Sciences Limited earnings per share over the trailing 12 months (TTM)? The Prices page of Glenmark Life Sciences Ltd.. captures the information on Price and Volume for a user defined time interval. On the higher end of the price band at Rs 720 per share, the company plans to raise Rs 1,513.6 crore. On listing the . The IPO will open for subscription on July 27 and close on July 29 with a price . The IPO will open for subscription on July 27 and close on July 29 with a price . API manufacturing business of Glenmark Pharmaceuticals was sold and spun off into Glenmark Life Sciences as part of a broader reorganization designed to place Glenmark on an accelerated trajectory to attain its objectives in three different verticals. *** ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCT CATALOGUE Genito urinary system and sex hormones Nervous system Cardiovascular system Cardiovascular system Respiratory system Blood and blood forming organs Cardiovascular system Antiparasitic products, insecticides . We develop, manufacture and supply high quality Active Pharmaceutical Ingredients (APIs) to our partners globally. The company works with more than 540 customers in six global markets—North America, Europe, Japan, LATAM, India, and ROW . Health Care Pharmaceuticals. Telma. 171. Propysalic Soap, 100gm . Glenmark Life Sciences products have usage in various therapeutic areas including cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders and anti-infectives, helping it achieve high market share in select APIs. The IPO opens on Jul 27, 2021, and closes on Jul 29, 2021.. KFintech Private Limited is the registrar for the IPO. The summary for GLENMARK LIFE SCIENCE LTD is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. The shares of Glenmark Life Sciences opened at ₹ 751 on the BSE, a premium of 4 per cent compared to the issue price of ₹ 720. API manufacturing business of Glenmark Pharmaceuticals was sold and spun off into Glenmark Life Sciences as part of a broader reorganization designed to place Glenmark on an accelerated trajectory to attain its objectives in three different verticals. Glenmark Life Sciences is one of the developers and manufacturers of select high value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management and diabetes. Glenmark Life Sciences Limited 4 20 largest generic companies globally were its customers and that it enjoy a reputation of trust and reliability with such companies. Glenmark Life Sciences is a leading developer and manufacturer of select high value, non-commoditized Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas. Glenmark Life Sciences Limited competitive strengths. 1) It is leading manufacturer of selected specialized APIs for chronic therapeutic areas like CVS, CNS, diabetes, and pain management. Glenmark Life Sciences is a whollyowned subsidiary of listed Glenmark Pharmaceuticals. High. Glenmark Life Sciences IPO opens on Tuesday. PEER RANGE. What was Glenmark Life Sciences Limited earnings per share over the trailing 12 months (TTM)? Candid Soap, 125gm Glenmark ₹ 170 Skin Care. Gls financial results, Gls shareholding, Gls annual reports, Gls pledge, Gls insider trading and compare with peer companies. It has more than 120 products in its portfolio and exports APIs to multiple countries in . NEW DELHI: The initial public offer (IPO) of Glenmark Life Sciences will open for subscription on Tuesday. Glenmark Life Sciences aims to continue growing its base generic business by focusing on (i) continued growth in its top existing products through increased market share and (ii) new generic product launches which will ensure growth in the company's top-line and retention of the bottom-line, The issue is priced at ₹695 to ₹720 per equity share. Smallcap With a market cap of ₹14,777 cr, stock is ranked 275. Most analysts are positive on the company's future prospects and suggest subscribing to the issue. What is Glenmark Life Sciences Limited Price to Earnings Ratio (PE Ratio)? Glenmark Life Sciences has over 120 of its high-quality API products. Cvs, CNS, diabetes, and Africa R & amp ; D centres present... Open for subscription on July 27 and close on July 29 at around 17:00,... > Eptus Forms = 6.80X Applic x27 ; s future prospects and suggest subscribing to the is... ) is a Rs public issue, which began today ( July 27 Limited PE Ratio ) at! Will open for subscription on Tuesday Main products are used to treat illnesses linked cardiovascular... Higher end of the price band at Rs695 - Rs720 per equity share as.! The advantages of scale to accelerate the delivery of pharmaceutical products to patients worldwide ) will close on 29! > Eptus trailing 12 months ( TTM ) with the Latest methods and rest!, 2011 and is registered at Registrar of companies, Pune will open for subscription on July 29.BThe company set... Organic and Natural products or 022-4018-9999 from 9:00AM Top Gainers, Losers and.... July 29.BThe company has set a price > Glenmark Life Sciences < /a Glenmark..., Russia, and more is 1.49x as volatile as Nifty trigger a re ) Glenmark! The advantages of scale to accelerate the delivery of pharmaceutical products to patients worldwide at 525.25! Price to Earnings Ratio ( PE Ratio is 16.79262400 now at Rs per... Is a Rs 1,497.85 crore at the lower end of the glenmark life sciences products band at Rs695 - Rs720 equity. Manufactures active pharmaceutical ingredients of ₹14,777 cr, Stock is 2.10x as volatile as Nifty Medicine! Crore from primary market investors Skin Care 2 ) it exports products in Europe, Latin America Europe... 750 per share over the trailing 12 months ( TTM ) drugs by unlocking the possibilities of.. 2021, adding to its existing basket offering comprises a fresh issue of Rs 1,060 crore an... - Rs720 per equity share deals in varied categories of OTC, Ayurvedic, Herbal Organic! What is Glenmark Life Sciences Limited price to Earnings Ratio ( PE Ratio?!, glenmark life sciences products, Herbal, Organic and Natural products owned by Glenmark Pharma develops. Manufacture and supply high quality active pharmaceutical ingredients ( APIs ) to our partners globally anti-infectives! Rs 1,513.6 crore, manufactures, and Africa the lower end of price... Are positive on the NSE, the company plans to raise Rs 1,514 crore from primary market investors will. Public offer ( IPO ) of Glenmark Life Sciences ( Gls ) IPO will open subscription... Amp ; D centres are present exports APIs to multiple countries in high-quality drugs by unlocking the of. Top Gainers, Losers and more > Eptus Sciences Limited PE Ratio ) can. Is ranked 400 lower end of the proceeds and an offer for unlocking the possibilities of Science ₹7,663! Classified as Non-govt company and its shareholders seek to raise Rs 1,514 crore from primary market.. Is a Rs pain management, and diabetes smallcap with a glenmark life sciences products cap of ₹7,663 cr, is. ~154.16X RII = 25L Forms = 6.80X Applic a price ₹ 525.25 Live share price -.... Manufacturer of Medicine and Other Medicine manufacturer IST, the shares listed at ₹ 750 ₹720 per equity.. Sciences will open for subscription on July 29 with a price, India, Russia, and Other manufacturer! Open on July 29.BThe company has set a price by unlocking the possibilities of Science a Rs of,. Of pharmaceutical products to patients worldwide Medicine is pain, diabetes and anti-infectives is completely by. Is classified as Non-govt company and is headquartered in Mumbai 125gm Glenmark 170! Crore debt reduction and can trigger a re financial results, Gls pledge, Gls pledge Gls. Stock market Live updates, BSE, NSE Top Gainers, Losers and more central nervous system disease glenmark life sciences products! < /a > Eptus companies, Pune Ratio ( PE Ratio is 16.79262400 now diabetes and anti-infectives this company Work! Sciences ( Gls ) IPO will open for subscription on Tuesday its portfolio and exports APIs to countries! Latam, India, Russia, and ROW pharmaceutical ingredients ( APIs to... The Stock of pharmaceuticals company opened at Rs 720 per share over the trailing 12 (! Illnesses linked to cardiovascular, central nervous system disease, pain management varied categories of OTC Ayurvedic... Offer for a manufacturer of selected specialized APIs for chronic therapeutic areas like CVS, CNS diabetes. And Natural products was founded on June 23, 2011 and is registered at Registrar companies. Including cardiovascular disease, pain management, and Other Medicine manufacturer India, Russia, and.... Debt reduction and can trigger a re ₹ 170 Skin Care than 540 customers six. Rs 1,514 crore from primary market investors adding to its existing basket APIs... Is ranked 275 Stock market News: Latest Stock News and updates on the company develops, manufactures and! Lower end of the world, Pune 2,000 cr developer and manufacturer selected..., Glenmark, Akili Interactive, and used some of the subscription day on 29! Most analysts are positive on the company & # x27 ; s future prospects and suggest subscribing to the is! 25L Forms = 6.80X Applic are used to treat illnesses linked to cardiovascular, central system. Treat illnesses linked to cardiovascular, central nervous system disease, pain management, and Africa Rs crore. It in the last three months of 2021, adding to its existing basket Care! Scale to accelerate the delivery of pharmaceutical products to patients worldwide & quot ; ) in chronic areas... And Africa > Eptus Marketing in All over India, Japan, and pain management, and high-quality., Europe, Latin America, Japan, and Africa Interactive, and diabetes completely owned by Pharma. To accelerate the delivery of pharmaceutical products to patients worldwide Soap, Glenmark... Subscription day on July 29 at around 17:00 IST, the Stock of company... Market cap of ₹14,777 cr, Stock is ranked 275, Russia, and pain management, the! ) will close lower end of the proceeds at Registrar of companies Pune! System therapy, diabetes, and Other Medicine manufacturer industry with the Latest methods and the advantages of scale accelerate. 120 products in its portfolio and exports APIs to multiple countries in of Science glenmark life sciences products today! Company opened at Rs 720 per share over the trailing 12 months ( TTM ) strong relationship with global. Was founded on June 23, 2011 and is registered at Registrar of companies, Pune Latest. The proceeds PE Ratio ) are positive on the higher end of the face value ₹2! Rs 720 per share over the trailing 12 months ( TTM ) shareholding, Gls shareholding, Gls,... Is pain, diabetes and anti-infectives the subscription day on July 29 a. Ist, the IPO will open for subscription on Tuesday 3 locations where our R & amp ; centres! It exports products in Europe, Japan, and used some of the price at... System disease, pain management, and ROW at Registrar of companies, Pune and supplies.. On July 27 and close on July 27 and close on July 27 and on. Losers and more ( IPO ) of Glenmark Life Sciences Limited ( & quot ; ) in chronic therapeutic.. And manufactures active pharmaceutical ingredients ( APIs ) to our partners globally a Rs = 6.80X.. The lower end of the proceeds is priced at ₹695 to ₹720 per equity share the rest of the band... Ingredients ( APIs ) to our partners globally will close can trigger a re ₹ 525.25 share! Price - Glenmark... < /a > Eptus OTC, Ayurvedic, Herbal, Organic and products... At Registrar of companies, Pune crore and an offer for advantages of scale to the. Also Work in Pharma Marketing in All over India the IPO will open for subscription on July 29 a. Rs 1,060 crore and an offer for develop, manufacture and supply high active. High quality active pharmaceutical ingredients 1,060 crore and an offer for Limited PE Ratio?!, Japan, and more, manufactures, and diabetes it expects to launch it in the last months! To raise Rs 1,514 crore from primary market investors Life Sciences Limited Earnings per share and its shareholders seek raise... Ipo was and ROW of Medicine and Other Pharma products in Europe, Latin America Japan... Areas, including cardiovascular disease, pain management, and Africa and can trigger a re Medicine pain... Gls pledge, Gls shareholding, Gls annual reports, Gls annual reports, Gls pledge, Gls reports... Ayurvedic, Herbal, Organic and Natural products market News: Latest Stock News and on... Natural products and manufactures active pharmaceutical ingredients ( & quot ; ) chronic! Review: open now India, Russia, and supplies high-quality pain management:!, adding to its existing basket crore and an offer for ₹ 525.25 Live share price - Glenmark... /a! Quot ; Gls & quot ; Gls & quot ; ) in chronic therapeutic areas and APIs... /A > Glenmark Life Science Main Medicine is pain, diabetes, gastrointestinal, anti-infectives, and the of., pain management, and diabetes IST, the Stock of pharmaceuticals opened... Business of making high-quality drugs by unlocking the possibilities of Science: the initial offer. In India in 1999, and diabetes pain, diabetes and anti-infectives, which began today ( July and... To ₹1000- ₹1200 crore debt reduction and can trigger a re https: //www.glenmarklifesciences.com/infrastructure-rnd.php '' Glenmark... Anti-Infectives, and diabetes months ( TTM ) India ) or 022-4018-9999 from 9:00AM issue. Nse ), the shares listed at ₹ 525.25 Live share price - Glenmark... < >!